- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Available formulations
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Dosages
| Maintenance treatment for asthma |
|---|
|
| Acute asthma attack |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
Central nervous system stimulation effects, expressed as overstimulation and hyperactivity, have been reported sporadically after inhalation of β2-sympathomimetics. These effects have primarily been seen in children younger than 12
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
Before prescribing formoterol, a bronchodilatory response should be confirmed by making an FEV1 measurement before and after beta-2 mimetics. An alternative to the lung function measurements in children aged less than 6 years is a good response to a LABA or SABA that has been administered. There is insufficient data known about the use of formoterol in children aged under 6 years.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Alpha- and beta-adrenoreceptor agonists | ||
|---|---|---|
| R03AA01 | ||
| Selective beta-2-adrenoreceptor agonists | ||
|---|---|---|
| R03AC02 | ||
| R03AC12 | ||
| R03AC03 | ||
| Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics | ||
|---|---|---|
| R03AK08 | ||
| R03AK11 | ||
| R03AK10 | ||
| R03AK07 | ||
| R03AK06 | ||
| Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids | ||
|---|---|---|
| R03AL01 | ||
| R03AL02 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
References
- AstraZeneca BV, SmPC Oxis (RVG 21026) 12-03-2024, www.geneesmiddeleninformatiebank.nl
- NVK, Richtlijn Astma bij Kinderen, 2013
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Changes
Changes
